<DOC>
	<DOC>NCT01356706</DOC>
	<brief_summary>Only few reports exist on long-term survival after minimally invasive liver surgery (MILS for colorectal liver metastases. No data are available assessing prognostic factors in the era of current modern treatment strategies. The aim of the current study is to analyze the long-term oncologic outcome after MILS for metastases from colorectal cancer and determine prognostic indicators.</brief_summary>
	<brief_title>Minimally Invasive Liver Surgery for Metastases From Colorectal Cancer: Oncologic Outcome and Prognostic Factors</brief_title>
	<detailed_description />
	<criteria>Patients with CRLM Surgery: resection and/or ablation preoperative chemotherapy and/or biological agents are allowed postoperative chemotherapy and/or biological agents are allowed simultaneous colorectal resection is allowed primary liver cancer benign liver tumors pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>liver metastases</keyword>
	<keyword>colorectal cancer</keyword>
	<keyword>surgery</keyword>
	<keyword>prognosis</keyword>
</DOC>